Evidence map›Paper›PMID 42548865›Full record

ArticleFood science & nutrition2026

Synergistic Anti-Lung Cancer Effects of Cytarabine and a NCBI-Registered

Abbas Asoudeh-Fard, Farnood Afrakhteh, Zahra Rahimi, Rakhshan Hakimelahi, Mohammad Bagher Nazari, Mohamad Mehdi Nemati, Abbas Fazlinia, Asghar Parsaei

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Food science & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abbas Asoudeh-FardInstitute Galilée University Sorbonne Paris North Paris France.ORCID https://orcid.org/0000-0002-6552-5268
Farnood AfrakhtehDepartment of Microbiology Islamic Azad University, Rasht Branch Rasht Iran.
Zahra RahimiNiko Gene Saba Biotech Company, Rayan Novin Pajohan Company Shiraz Iran.
Rakhshan HakimelahiDepartment of Chemistry Shi. C, Islamic Azad University, Shiraz Branch Shiraz Iran.ORCID https://orcid.org/0000-0003-1779-2692
Mohammad Bagher NazariDepartment of Microbiology Islamic Azad University, Shiraz Branch Shiraz Iran.
Mohamad Mehdi NematiPharmaceutical Sciences Research Center Shiraz University of Medical Sciences Shiraz Iran.
Abbas FazliniaDepartment of Chemistry Islamic Azad University, Shiraz Branch Shiraz Iran.
Asghar ParsaeiZand Institute of Higher Education Shiraz Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer remains one of the leading causes of cancer-related mortality worldwide, and although Cytarabine (CYT) exhibits anticancer activity, its clinical application is often restricted by dose-dependent toxicity. In this study, we investigated the synergistic anticancer potential of the NCBI-registered probiotic

Indexed as

A549 cellsapoptosischemosensitizationcytarabinelung cancerprobioticStreptococcus thermophilus

Identifiers

PMID42548865
PMCPMC13429938

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.